Brief: Cosmo Pharmaceuticals Announces Approval For Opaganib As Treatment Of Covid-19 In Italy

Cosmo NV

06/04/2020 06:11

April 6 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * ANNOUNCES REDHILL'S APPROVAL OF COMPASSIONATE USE OF
OPAGANIB
FOR TREATMENT OF COVID-19 IN ITALY
    * INITIALLY, 140 PATIENTS ARE PLANNED TO BE TREATED IN THREE
MAJOR
HOSPITALS IN NORTHERN ITALY, ONE OF CURRENT MAJOR EPICENTERS OF
PANDEMIC.
    * COSMO AND REDHILL HAVE AGREED THAT COSMO WILL BECOME
EXCLUSIVE
OR MAIN COMMERCIAL SUPPLIER IN FUTURE

Source text for Eikon:  ID:nTENxcv3ta 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))